RMD logo

ResMed (RMD)

Profile

Full Name

ResMed Inc.

Ticker Symbol

RMD

Exchange

NYSE

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

June 2, 1995

Indexes

S&P 500

Website

http://www.resmed.com

Employees

9980

Key Details

Price

$217.98

Market Cap

Last Dividend

$0.53

TTM Dividend Yield

0.95%

Annual Revenue

$4.69B(+10.95% YoY)

Annual EPS

$6.92(+13.63% YoY)

PE Ratio

25.74

Next earnings date

Apr 25, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$217.98
RMD price is $217.98

Price All-time High

$297.36
RMD price is currently -26.69% below its historical high of $297.36

Price Today Change

-1.94%
RMD price is down -1.94% today

Price YTD Change

-4.54%
RMD price is down -4.54% since January 1st

Price 1-year Change

+17.98%
RMD price is up +17.98% year-on-year

Price 3-year Change

-11.55%
RMD price is down -11.55% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$32.01B
RMD market capitalization is $32.01 billion

Market Cap 3-year Change

-11.19%
RMD market capitalization is down -11.19% over the past 3 years

Market Cap All-time High

$43.32B
RMD market capitalization is currently -26.10% below its historical high of $43.32 billion

Market Cap Sector Rank

96.64%
RMD market capitalization is higher than 96.64% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.01%
RMD shares outstanding is down -0.01% year-on-year

Shares Outstanding 3-Year Change

+0.41%
RMD shares outstanding is up +0.41% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.71
RMD beta is 0.71

200-day SMA

$230.76
RMD price is currently -5.54% below its 200-day simple moving average

50-day SMA

$232.67
RMD price is currently -6.32% below its 50-day simple moving average

RSI

46.21
RMD 14-day relative strength index is 46.21

Volume

0.69
RMD 30-day relative volume is 0.69

ATR

$5.48
RMD average true range is $5.48

10-day Historical Volatility

15.51%
RMD 10-day historical volatility is 15.51%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.53
RMD last dividend was $0.53 per share, with an ex-dividend date of February 13, 2025

Next Dividend

-
RMD next dividend has not yet been announced

Dividend per share

Dividend Per Share

$1.92
RMD annual dividend per share is $1.92

Dividend per share Sector Rank

68.6%
RMD annual dividend per share is higher than 68.6% of companies in Healthcare sector

Dividend per share 1-Year Change

+9.09%
RMD annual dividend per share is up +9.09% year-on-year

Dividend per share 3-Year Change

+23.08%
RMD annual dividend per share is up +23.08% over the past 3 years

Dividend yield

Dividend Yield

0.88%
RMD annual dividend yield is 0.88%

Dividend yield Sector Rank

27.06%
RMD annual dividend yield is higher than 27.06% of companies in Healthcare sector

Other

Payout Ratio

27.65%
RMD annual payout ratio is 27.65%

Dividends Paid

$282.32M
RMD annual dividends paid is $282.32 million

Free Cash Flow

$1.29B
RMD annual free cash flow is $1.29 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$4.69B
RMD annual revenue is $4.69 billion

Revenue Analysts Estimate

$5.11B
RMD annual revenue is currently -8.38% lower than the consensus analysts' forecast

Revenue 1-year Change

+10.95%
RMD annual revenue is up +10.95% year-on-year

Revenue Sector Rank

91.66%
RMD annual revenue is higher than 91.66% of companies in Healthcare sector

EPS

EPS

$6.92
RMD annual earnings per share is $6.92

EPS Analysts Estimate

$9.46
RMD annual earnings per share is currently -26.86% lower than the consensus analysts' forecast

EPS 1-year Change

+13.63%
RMD annual earnings per share is up +13.63% year-on-year

EPS Sector Rank

96.89%
RMD annual earnings per share is higher than 96.89% of companies in Healthcare sector

Profit

Gross Profit

$2.66B
RMD annual gross profit is $2.66 billion

Gross Margin

56.67%
RMD annual gross profit margin is 56.67%

Operating Profit

$1.38B
RMD annual operating income is $1.38 billion

Operating Margin

29.54%
RMD annual operating profit margin is 29.54%

Net Income

$1.02B
RMD annual net profit is $1.02 billion

Net Margin

21.79%
RMD annual net profit margin is 21.79%

Expenses

Total Expenses

$3.30B
RMD annual total expenses is $3.30 billion

Operating Expenses

$1.27B
RMD annual total operating expenses is $1.27 billion

Cost Of Goods Sold

$2.03B
RMD annual cost of goods sold is $2.03 billion

Selling, General & Administrative Expenses

$917.14M
RMD annual SGA is $917.14 million

Depreciation And Amortization

$216.21M
RMD annual depreciation & amortization is $216.21 million

Interest Expense

$45.71M
RMD annual interest expense is $45.71 million

Income Tax

$243.85M
RMD annual income tax is $243.85 million

EBIT & EBITDA

EBIT

$1.38B
RMD annual earnings before interest & taxes is $1.38 billion

EBITDA

$1.60B
RMD annual EBITDA is $1.60 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$6.87B
RMD annual total assets is $6.87 billion

Non Current Assets

$4.51B
RMD annual long term assets is $4.51 billion

Current Assets

$2.36B
RMD annual total current assets is $2.36 billion

Cash And Cash Equivalents

$238.36M
RMD annual cash & cash equivalents is $238.36 million

Accounts Receivable

$837.27M
RMD annual accounts receivable is $837.27 million

Inventory

$822.25M
RMD annual inventory is $822.25 million

Liabilities

Total Liabilities

$2.01B
RMD annual total liabilities is $2.01 billion

Long Term Liabilities

$1.10B
RMD annual total long term liabilities is $1.10 billion

Current Liabilities

$910.65M
RMD annual total current liabilities is $910.65 million

Accounts Payable

$237.73M
RMD annual accounts payable is $237.73 million

Debt

Total Debt

$873.93M
RMD annual total debt is $873.93 million

Total Debt 1-year Change

-44.68%
RMD annual total debt is down -44.68% year-on-year

Long Term Debt

$838.76M
RMD annual long term debt is $838.76 million

Short Term Debt

$35.18M
RMD annual short term debt is $35.18 million

Equity & Capital

Shareholders Equity

$4.86B
RMD annual stockholders equity is $4.86 billion

Book Value

$4.86B
RMD annual book value is $4.86 billion

Retained Earnings

$4.99B
RMD annual retained earnings is $4.99 billion

Working Capital

$1.45B
RMD annual working capital is $1.45 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

$1.40B
RMD annual cash flow from operations is $1.40 billion

Cash From Operations 1-year Change

+102.11%
RMD annual cash flow from operations is up +102.11% year-on-year

Cash From Investing

-$269.78M
RMD annual cash flow from investing activities is -$269.78 million

Cash From Investing 1-year Change

+76.74%
RMD annual cash flow from investing activities is up +76.74% year-on-year

Cash From Financing

-$1.12B
RMD annual cash flow from financing activities is -$1.12 billion

Cash From Financing 1-year Change

-364.69%
RMD annual cash flow from financing activities is down -364.69% year-on-year

CAPEX

CAPEX

$114.86M
RMD annual capital expenditures is $114.86 million

CAPEX 1-year Change

-14.29%
RMD annual capital expenditures is down -14.29% year-on-year

Free Cash Flow

Free Cash Flow

$1.29B
RMD annual free cash flow is $1.29 billion

Free Cash Flow 1-year Change

+130%
RMD annual free cash flow is up +130% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

56.67%
RMD annual gross profit margin is 56.67%

Operating Margin

29.54%
RMD annual operating profit margin is 29.54%

Net Margin

21.79%
RMD annual net profit margin is 21.79%

ROA & ROE

ROA

14.99%
RMD annual return on assets is 14.99%

ROE

22.70%
RMD annual return on equity is 22.70%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

25.74
RMD price to earnings ratio is 25.74

PE Ratio Sector Rank

49.51%
RMD price to earnings ratio is higher than 49.51% of companies in Healthcare sector

PB Ratio

PB Ratio

6.09
RMD price to book ratio is 6.09

PB Ratio Sector Rank

86.45%
RMD price to book ratio is higher than 86.45% of companies in Healthcare sector

PS Ratio

PS Ratio

6.50
RMD price to sales ratio is 6.50

PS Ratio Sector Rank

72.29%
RMD price to sales ratio is higher than 72.29% of companies in Healthcare sector

Enterprise value

Enterprise Value

$32.33B
RMD enterprise value is $32.33 billion

Enterprise Value Sector Rank

96.37%
RMD enterprise value is higher than 96.37% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

18.95
RMD EV/EBITDA is 18.95

EV/EBITDA Sector Rank

90.46%
RMD EV/EBITDA is higher than 90.46% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

2.59
RMD annual current ratio is 2.59

Quick Ratio

1.69
RMD annual quick ratio is 1.69

Leverage

Debt To Equity

0.15
RMD annual debt to equity ratio is 0.15

Interest Coverage Ratio

30.28
RMD annual interest coverage ratio is 30.28

Risk & Stability

Piotroski F-Score

9
RMD piotroski f-score is 9

Altman Z-Score

12.18
RMD altman z-score is 12.18

Analyst ratings

Recent major analysts updates

Mar 5, 25 Stifel
Hold
Mar 5, 25 Citigroup
Buy
Jan 31, 25 Piper Sandler
Neutral
Jan 31, 25 Needham
Hold
Jan 31, 25 Keybanc
Overweight
Jan 31, 25 JP Morgan
Overweight
Jan 10, 25 Piper Sandler
Neutral
Dec 13, 24 Stifel
Hold
Oct 25, 24 RBC Capital
Sector Perform
Oct 25, 24 Needham
Hold

Institutional Ownership

Similar stocks

A logo
Agilent Technologies (A)
HUM logo
Humana (HUM)
CAH logo
Cardinal Health (CAH)
IDXX logo
IDEXX Laboratories (IDXX)
ALNY logo
Alnylam Pharmaceuticals (ALNY)
IQV logo
IQVIA Holdings (IQV)
CNC logo
Centene (CNC)
BeiGene (ONC)
GEHC logo
GE HealthCare Technologies (GEHC)
  • What is the ticker symbol for ResMed?
  • Does ResMed pay dividends?
  • What sector is ResMed in?
  • What industry is ResMed in?
  • What country is ResMed based in?
  • When did ResMed go public?
  • Is ResMed in the S&P 500?
  • Is ResMed in the NASDAQ 100?
  • Is ResMed in the Dow Jones?
  • When was ResMed's last earnings report?
  • When does ResMed report earnings?
  • Should I buy ResMed stock now?

What is the ticker symbol for ResMed?

The ticker symbol for ResMed is NYSE:RMD

Does ResMed pay dividends?

Yes, ResMed pays dividends. The last payment was $0.53, with an ex-dividend date on February 13, 2025

What sector is ResMed in?

ResMed is in the Healthcare sector

What industry is ResMed in?

ResMed is in the Medical Instruments & Supplies industry

What country is ResMed based in?

ResMed is headquartered in United States

When did ResMed go public?

ResMed's initial public offering (IPO) was on June 2, 1995

Is ResMed in the S&P 500?

Yes, ResMed is included in the S&P 500 index

Is ResMed in the NASDAQ 100?

No, ResMed is not included in the NASDAQ 100 index

Is ResMed in the Dow Jones?

No, ResMed is not included in the Dow Jones index

When was ResMed's last earnings report?

ResMed's most recent earnings report was on Jan 30, 2025

When does ResMed report earnings?

The next expected earnings date for ResMed is Apr 25, 2025

Should I buy ResMed stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page